The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling

  1. Januka S Athukoralage
  2. Shirley Graham
  3. Christophe Rouillon
  4. Sabine Grüschow
  5. Clarissa M Czekster
  6. Malcolm F White  Is a corresponding author
  1. Biomedical Sciences Research Complex, School of Biology, University of St Andrews, United Kingdom

Peer review process

This article was accepted for publication as part of eLife's original publishing model.

History

  1. Version of Record published
  2. Accepted Manuscript published
  3. Accepted
  4. Received

Decision letter

  1. Blake Wiedenheft
    Reviewing Editor; Montana State University, United States
  2. Gisela Storz
    Senior Editor; National Institute of Child Health and Human Development, United States
  3. Martin Lawrence
    Reviewer
  4. Rotem Sorek
    Reviewer; Weizmann Institute of Science

In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

Thank you for submitting your article "The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Gisela Storz as the Senior Editor. The following individuals involved in review of your submission have agreed to reveal their identity: Philip Kranzusch (Reviewer #1); Martin Lawrence (Reviewer #2); Rotem Sorek (Reviewer #3).

The reviewers universally agree that this work is nearly ready for publication. No additional experiments are requested.

Summary:

It is becoming increasingly clear that cyclic nucleotides play a critical role in the host response to a viral infection and that viruses have evolved mechanisms to intercept these signaling molecules. In this work, the authors focused on the synthesis of cyclic-oligo-adenylate (cA4) produced by the type-III CRISPR system in Sulfolobus solfataricus, the immune proteins that are activated by cA4, and viral anti-CRISPR proteins that degrade cA4. Biochemical data is used to build a kinetic model, which helps explains how cyclases and ring nucleases govern cyclic nucleotide levels and determine infection outcomes in virus-host conflict.

Essential revisions:

1) Rates of cA4 synthesis by the S. solfataricus Csm complex have been previously measured (Rouillon et al., 2018; Rouillon et al., 2019). These rates should be incorporated into the mathematical model to understand how the relative rates of cA4 synthesis and cA4 degradation may influence effector function dynamics.

2) The current model does not take into account previously observations from the lab demonstrating that cA4 synthesis wanes after ~10 min if no new activating RNA is delivered to the system. Please discuss this in the context of your model.

https://doi.org/10.7554/eLife.55852.sa1

Author response

Essential revisions:

1) Rates of cA4 synthesis by the S. solfataricus Csm complex have been previously measured (Rouillon et al., 2018; Rouillon et al., 2019). These rates should be incorporated into the mathematical model to understand how the relative rates of cA4 synthesis and cA4 degradation may influence effector function dynamics.

We agree that this would strengthen the model. We have determined the rate of cA4 synthesis (Figure 2—figure supplement 2) from previously published data (Rouillon et al., 2018) and have incorporated this into the model. We have also adjusted the kinetic parameters of our model to the reaction temperature of 70 °C, which better represents infection kinetics at the growth temperature of S. solfataricus. We have also increased the cellular RNA concentration to 1000 µM, from 100 µM in the previous model, which we believe better represents cellular conditions and means that RNA is never fully depleted in the simulations. For comparison and transparency, we include a supplementary version of Figure 6 with simulations starting at fixed cA4 concentrations (as in the original submission) carried with the current model as per our initial submission. See Author response images 1 and 2. Ultimately, the changes we have made, including incorporation of the rate of cA4 synthesis do not radically alter any of our previous conclusions.

Author response image 1
Author response image 2

2) The current model does not take into account previously observations from the lab demonstrating that cA4 synthesis wanes after ~10 min if no new activating RNA is delivered to the system. Please discuss this in the context of your model.

This query relates to point 1, and we have addressed this point in the new model, which now incorporates the time dependent synthesis of cA4, dependent on the concentration of target RNA.

https://doi.org/10.7554/eLife.55852.sa2

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Januka S Athukoralage
  2. Shirley Graham
  3. Christophe Rouillon
  4. Sabine Grüschow
  5. Clarissa M Czekster
  6. Malcolm F White
(2020)
The dynamic interplay of host and viral enzymes in type III CRISPR-mediated cyclic nucleotide signalling
eLife 9:e55852.
https://doi.org/10.7554/eLife.55852

Share this article

https://doi.org/10.7554/eLife.55852